Navigation Links
Weight-Loss Surgery Beat Drugs for Cutting Diabetes in Very Obese
Date:4/16/2012

By Kathleen Doheny
HealthDay Reporter

MONDAY, April 16 (HealthDay News) -- A bariatric surgical procedure is more likely than medicine to improve or even reverse type 2 diabetes in very obese patients, a new small study indicates.

Italian researchers compared standard diabetes medicine with a surgical procedure known as the laparoscopic sleeve gastrectomy, and while 80 percent of those treated with the surgery had remission of their diabetes within 18 months, none of those treated with medicine did.

"In our opinion, 80 percent diabetes resolution is a dramatically excellent result, compared with results of a medical approach in which there's not diabetes resolution," said lead researcher Dr. Nicola Basso, a professor of surgery at the University of Rome, Sapienza.

All of those who had surgery and had diabetes less than 10 years reversed it, Basso said.

The study appeared online April 16 in the Archives of Surgery.

In the procedure, doctors remove about 85 percent of the stomach and shape the remaining portion into a tube or sleeve. Fewer calories can be eaten, and weight loss is the result.

"At present, we think that sleeve gastrectomy may be considered the surgical procedure of choice in treating 'diabesity,'" said Basso.

The researchers assigned 30 patients to the surgery group and another 30 to the medicine group. All had a body-mass index (BMI) of 35 or higher. With BMI, which takes both height and weight into account, 30 is the beginning of the obese category.

A person who is 5-foot-10 and weighs 250 pounds has a BMI of nearly 36.

Basso's team followed the patients for 18 months to see what effect the treatments had on their diabetes and other health measures.

The surgery group's average BMI went from 41 to about 28. The medicine group's BMI, 39 on average at the start, went up slightly.

Those who had the surgery had improvements in other areas. Sleep apnea dropped from 50 percent to 10 percent. After surgery, patients reduced their use of medicine for high blood pressure and cholesterol problems.

None in the medicine group reversed their diabetes. Their need for high blood pressure medicine and cholesterol medicines increased, although not significantly. Their sleep apnea did not change.

The study results are not surprising, said Dr. Ronald Goldberg, a professor of medicine at the Diabetes Research Institute at the University of Miami Miller School of Medicine.

"It's fairly in line with previous research using different bypass procedures," he said.

The latest findings could be very good news for very obese patients with diabetes, he said.

"The milder type is much more likely to go into remission than someone who has longstanding or complicated diabetes," he said. The procedure is worth consideration by someone who is very obese and has type 2 diabetes, he added.

The cost of the procedure in the United States is between $10,000 and $15,000.

"There is no question that over the short term, surgery has to be more expensive," Goldberg said. "But with time, the increased cost of managing diabetes, and particularly its complications, would make a cost-benefit comparison more meaningful."

More information

To learn more about diabetes, visit the American Diabetes Association.

SOURCES: Nicola Basso, M.D., Ph.D., professor, surgery, University of Rome, Sapienza; Ronald Goldberg, M.D, endocrinologist and professor, medicine, University of Miami Miller School of Medicine; April 16, 2012, Archives of Surgery, online


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Weight-Loss Surgeries May Beat Standard Treatments for Diabetes
2. Weight-Loss Surgery Seems Safe for Kidney Disease Patients
3. Mid-morning snacking may sabotage weight-loss efforts
4. Weighing Weight-Loss Programs
5. Weight Watchers Produces Bigger Losers Than Standard Weight-Loss Care
6. U.S. Women Using Dangerous Weight-Loss Pill 2 Years After Recall
7. Weight-Loss Surgery Gains More Practitioners
8. Rigorous Exercise May Boost Benefits of Weight-Loss Surgery
9. Weight-loss surgery cost-effective for all obese
10. Weight-Loss Surgery Helps Less Obese Patients: Study
11. Can Weight-Loss Surgery Reverse Common Cause of Infertility?
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Weight-Loss Surgery Beat Drugs for Cutting Diabetes in Very Obese
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... Maryland (PRWEB) , ... June 24, 2016 , ... ... Angels is actively feeding the Frederick area economy by obtaining investment capital for ... over the past 2½ years that have already resulted in more than a ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology: